bioindustry park silvano fumero and biopmed
DESCRIPTION
Marseille MET3 Conference presentation. 2nd April 2012.TRANSCRIPT
www.bioindustrypark.eu - [email protected]
Fabrizio Conicella – [email protected]
1. Bioindustry Park Silvano Fumero and
bioPmed
2. Bioprotech: overview
3. Bioindustry Park and Bioprotech
4. Lesson learned
Contents
Science park
specialised in health
care
22.000 sqm labs and
office spaces for
companies
Conference center
Consultancy in
biomanagement
Incubator
R&D service delivery
R&D shared facility
Cluster managing
company focused in
health care: bioPmed
www.bioindustrypark.eu
www.biopmed.eu
Bioindustry Park Silvano Fumero
The “traditional approach”
(One problem, one technology, one solution)
The “NEW” approach”
(Converging technologies)
- Up to 250 companies working specifically in
health care
- Over xx.000 companies working in ICT,
Mechatronics, New Materials, textiles, etc
The bioPmed “smart”approach…
80 bioPmed cluster CORE MEMBERS
share the approach of an Healthcare cluster aiming at
“Overlapping different technological knowledge to reach innovative solutions to
unmet medical needs and ensure a better future
Impact on Industry-research collaborations
The bioPmed pillars of action
www.biopmed.eu
And its supporting intitutions
The bioPmed community
BioCulture
80 core
member
Why to internationalize??? • Problems are global, Markets are global, finance is more and
more global, science is global, , optimizing health care costs is a global trend…......…..
• Big players are “global”: they are acting following a global strategy
• Small/medium players are willing to be global but…. – Lack of culture and skills
– Too focused on scientific development more than to company development
– Not enough resources
– Need for partnerships
• Critical mass in R&D and innovative companies become critical factors for territorial development
• Financial resources are scarce: single actors and single territories can’t afford the entire spectrum of investments of R&D to be competitive in every sector
• Lower transfer of public resources to R&D facilities
• Need to maximise positive impact of investments realised (job creation and sustainability)
• Local policies are interconnected (e.g. EU influence..)
Reg
ion
s
C
om
pan
ies&
R&
D
Why to cooperate in the mediterranean
area? • Advantages from the cooperative approach:
– Starting from local assets exploiting synergies between
territories
– Win-win activities: complementarity approach (value effective)
– Exploiting in a cooperative way the best components of a process also if they are located in a different territory
– Minimize “bad” competition
– Sustainability
– Minimize duplications of activities
It requires a cultural shift!!!!!
10
Project full title: Improve research capacities of the Centre of Biotechnology
of Sfax (Tunisia) in Bio-Processes for biotech applications, tying up with the
European Research Area
keywords: Biotech, bioprocesses, joint research, technology
transfer, ERA, regional impact, research policies
Duration (month): 30, from 1st November 2010
Project coordinator: CBS Sfax
Call: FP7-INCO-2010-6: Integrating Europe's neighbours into the ERA -WIDE
activity
BioProtech Project Overview
bioprotech.org
Project consortium partners
Participant No. Participant organisation name Short Name Country
1 (Coordinator) Centre of Biotechnology of Sfax CBS Tunisia
2 International Centre for Genetic
Engineering and Biotechnology ICGEB Italy
3 National Institute of Applied Sciences
of Toulouse INSA France
4 Steinbeis Research Center SFZ Germany
5 Bioindustry Park Silvano
Fumero/bioPMed BiPCa Italy
6 University of Claude Bernard Lyon UCBL France
Bioprotech project
Project management
Dissemination WP4
WP2
WP5
WP3
WP6
WP 1
Bioprotech goals The following objectives will be addressed by BioProtech:
Improvement of the technological background and
research skills
Build up the knowledge base for commercialisation of
research results
Build up knowledge about European research funding
instruments
Increase the visibility of CBS on a local and European
level
Improvement of the future biotechnology development
at CBS, tying up with the European Research Area
TT support approach
Global trends
analysis
Local ecosystem
action/clustering
action
CBS situation
analysis
General
Need analisys/matching
with CBS analisys
TT/networking
guidelines Training
planning
Local situation
Report
D2.1
D2.2 D2.3
D2.5
Local situation
implementation
Task 2.1 Task 2.1
Task 2.2
Task 2.3
Map existing technology transfer
activities
Training, coaching
and awareness to
commercialisation of
research results
Build up local customer
and
supporter/collaborator
network
D2.4 Training
material
• Human resources are a key factor
• General training on TT is not perceived as useful:
specific/need focused training is well accepted/requested
• Avoid fire and forget activities: coaching and follow-up
caractherised by a specialistc/sectorial focus
• Community bulding approach as tool to growth, also
internationally
• Usually science is not a problem…exploitation at local
leve is a problem..
• Identify direct positive impact on the local system as a
driver
• It takes time…………
Lesson learned..up to now
Example of support • Start-up: Production of antigens, antibodies and
diagnosis kit developement (2008)
• Specific critical analisys of business idea (2010)
• Identification of scientifc assets/market assets/USP and
strategic advice (2010)
• Coaching in drafting business plan toghether with a
Tunisian consultants (2010)
• Support in developing a presentation for an elevator
pitch (US based investors) (2011). Identified as selected
project for a business trip in US for identification of
investors and analisys of market opportunities
BIOtechRDP
bioPmed @ Bioindustry Park Silvano Fumero S.p.A.
Via Ribes, 5 10010 Colleretto Giacosa (TO) Italy Tel. +39-0125-561311 Fax +39-0125-538350 [email protected] www.biopmed.eu www.bioindustrypark.eu
Is the team that wins not
the single player…